Literature DB >> 15853357

The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide.

Yahel Vakrat-Haglili1, Lev Weiner, Vlad Brumfeld, Alexander Brandis, Yoram Salomon, Brian McLlroy, Brian C Wilson, Anna Pawlak, Malgorzata Rozanowska, Tadeusz Sarna, Avigdor Scherz.   

Abstract

Generation of reactive oxygen species (ROS) is the hallmark of important biological processes and photodynamic therapy (PDT), where ROS production results from in situ illumination of certain dyes. Here we test the hypothesis that the yield, fate, and efficacy of the species evolved highly depend on the dye's environment. We show that Pd-bacteriopheophorbide (Pd-Bpheid), a useful reagent for vascular targeted PDT (VTP) of solid tumors, which has recently entered into phase II clinical trials under the code name WST09 (trade name TOOKAD), forms appreciable amounts of hydroxyl radicals, superoxide radicals, and probably hydrogen peroxide in aqueous medium but not in organic solvents where singlet oxygen almost exclusively forms. Evidence is provided by pico- and nanosecond time-resolved spectroscopies, ESR spectroscopy with spin-traps, time-resolved singlet oxygen phosphorescence, and chemical product analysis. The quantum yield for singlet oxygen formation falls from approximately 1 in organic solvents to approximately 0.5 in membrane-like systems (micelles or liposomes), where superoxide and hydroxyl radicals form at a minimal quantum yield of 0.1%. Analysis of photochemical products suggests that the formation of oxygen radicals involves both electron and proton transfer from (3)Pd-Bpheid at the membrane/water interface to a colliding oxygen molecule, consequently forming superoxide, then hydrogen peroxide, and finally hydroxyl radicals, with no need for metal catalysis. The ability of bacteriochlorophyll (Bchl) derivatives to form such radicals upon excitation at the near infrared (NIR) domain opens new avenues in PDT and research of redox regulation in animals and plants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853357     DOI: 10.1021/ja046210j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  45 in total

1.  Photophysics of a protein-bound derivative of malachite green that sensitizes the production of singlet oxygen.

Authors:  Lea Dichmann; Mikkel Bregnhøj; Han Liu; Michael Westberg; Thomas B Poulsen; Michael Etzerodt; Peter R Ogilby
Journal:  Photochem Photobiol Sci       Date:  2021-03-15       Impact factor: 3.982

2.  Singlet oxygen generation by UVA light exposure of endogenous photosensitizers.

Authors:  Jürgen Baier; Tim Maisch; Max Maier; Eva Engel; Michael Landthaler; Wolfgang Bäumler
Journal:  Biophys J       Date:  2006-06-02       Impact factor: 4.033

3.  Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland.

Authors:  Zheng Huang; Masoom A Haider; Susan Kraft; Qun Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel
Journal:  Lasers Surg Med       Date:  2006-08       Impact factor: 4.025

4.  Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production.

Authors:  Pawel Mroz; Jayeeta Bhaumik; Dilek K Dogutan; Zarmeneh Aly; Zahra Kamal; Laiqua Khalid; Hooi Ling Kee; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  Cancer Lett       Date:  2009-04-05       Impact factor: 8.679

5.  Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia.

Authors:  Huiying Ding; Haijun Yu; Ying Dong; Ruhai Tian; Gang Huang; David A Boothman; Baran D Sumer; Jinming Gao
Journal:  J Control Release       Date:  2011-08-23       Impact factor: 9.776

6.  Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

Authors:  Nicola J Farrer; Luca Salassa; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-11-11       Impact factor: 4.390

7.  Vascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.

Authors:  N Betrouni; S Boukris; F Benzaghou
Journal:  Lasers Med Sci       Date:  2017-06-01       Impact factor: 3.161

8.  Photophysical Characterization of Imidazolium-Substituted Pd(II), In(III), and Zn(II) Porphyrins as Photosensitizers for Photodynamic Therapy.

Authors:  Hooi Ling Kee; Jayeeta Bhaumik; James R Diers; Pawel Mroz; Michael R Hamblin; David F Bocian; Jonathan S Lindsey; Dewey Holten
Journal:  J Photochem Photobiol A Chem       Date:  2008-12-15       Impact factor: 4.291

9.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

10.  Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.

Authors:  Ying-Ying Huang; Thiagarajan Balasubramanian; Eunkyung Yang; Dianzhong Luo; James R Diers; David F Bocian; Jonathan S Lindsey; Dewey Holten; Michael R Hamblin
Journal:  ChemMedChem       Date:  2012-10-12       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.